Skip to main content

Advertisement

Log in

A rare parasitic infection: visceral leishmaniasis case after gastric cancer treatment

  • case report
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Summary

We present a case of Visceral Leishmaniasis (VL) in a patient with gastric cancer treated with chemoradiotherapy. A 69-year-old man with gastric carcinoma had been treated with total gastrectomy, lymphadenectomy and postoperative radiotherapy with chemotherapy. Then 3 years after treatment, due to pancytopenia with progressive trombocytopenia and splenomegaly, bone marrow examination was performed and Leishmania spp. amastigotes were diagnosed. When antibiotherapy was completed, splenomegaly was eliminated and the laboratory results became normal. VL should be kept in mind in the differential diagnosis of patients, even adults, with splenomegaly, trombocytopenia and a history of contact with dogs in endemic countries such as Turkey.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1a,b

References

  1. Chan BA, Jang RW, Wong RK, Swallow CJ, Darling GE, Elimova E. Improving outcomes in resectable gastric cancer: a review of current and future strategies. Oncology. 2016;30:635–45.

    PubMed  Google Scholar 

  2. Travi BL. Canine visceral leishmaniasis: diagnosis and management of the reservoir living among us. Plos Negl Trop Dis. 2018;11:12.

    Google Scholar 

  3. Oztoprak N, et al. An adult case of visceral leishmaniasis in a province of Black-Sea region, Turkey. Mikrobiyol Bul. 2010;44(4):671–7.

    PubMed  Google Scholar 

  4. Ozbel Y. A survey on canine leishmaniasis in western Turkey by parasite, DNA and antibody detection assays. Acta Trop. 2000;74(1):1–6.

    Article  CAS  PubMed  Google Scholar 

  5. WHO, Map. Status of endemicity of visceral leishmaniasis, worldwide. 2015. http://www.who.int/leishmaniasis/burden/Status_of_endemicity_of_VL_worldwide_2015_with_imported_cases.pdf?ua=1.

    Google Scholar 

  6. Sundar S. Leishmaniasis, Harrison’s P.I.M. 19th ed. 2015. pp. 1387–98. Chapter 251.

    Google Scholar 

  7. Bern C, Adler-Moore J, Berenguer J, et al. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis. 2006;43(7):917–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to the patient for consenting to publication of his clinical data. We thank staff members at the hospital. And we thank to Dr. Semin Ayhan and Dr. Simal Coban from the Department of Pathology, for their contributions in reviewing the tissue blocks.

Funding

No external funding was used in preparing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alkim Yolcu.

Ethics declarations

Conflict of interest

A. Yolcu, A. Dirican, G.G. Ozturk, C.B. Cetin, and I. Aydogdu declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yolcu, A., Dirican, A., Ozturk, G.G. et al. A rare parasitic infection: visceral leishmaniasis case after gastric cancer treatment. memo 11, 345–347 (2018). https://doi.org/10.1007/s12254-018-0437-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-018-0437-6

Keywords

Navigation